{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T21:52:20Z","timestamp":1794433940219,"version":"4.9.1"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T00:00:00Z","timestamp":1727308800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology Cardiovascular Risk and Prevention"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.ijcrp.2024.200338","type":"journal-article","created":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T15:24:24Z","timestamp":1727537064000},"page":"200338","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Diabetic cardiomyopathy: pathophysiology, imaging assessment and therapeutical strategies"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-2348-826X","authenticated-orcid":false,"given":"Vincenzo","family":"Rizza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara","family":"Tondi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo Maria","family":"Patti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damiano","family":"Cecchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Lombardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Perone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Ambrosetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manfredi","family":"Rizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Cianflone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Maranta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcrp.2024.200338_bib1","article-title":"Implications of underlying mechanisms for the recognition and management of diabetic cardiomyopathy","volume":"2017","author":"Liu","year":"2017","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.ijcrp.2024.200338_bib2","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12933-024-02135-z","article-title":"Characterizing diabetic cardimyopathy: baseline results from the ARISE-HF trial","volume":"23","author":"Jannuzzi","year":"2024","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.ijcrp.2024.200338_bib3","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1093\/eurheartj\/ehad192","article-title":"2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes","volume":"44","author":"Marx","year":"2023","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.ijcrp.2024.200338_bib4","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11154-010-9131-7","article-title":"Diabetic cardiomyopathy, causes and effects","volume":"11","author":"Boudina","year":"2010","journal-title":"Rev. Endocr. Metab. Disord."},{"issue":"4","key":"10.1016\/j.ijcrp.2024.200338_bib5","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCRESAHA.117.311586","article-title":"Diabetic cardiomyopathy: an update of mechanisms contributing to this clinical entity","volume":"122","author":"Jia","year":"2018","journal-title":"Circ. Res."},{"issue":"25","key":"10.1016\/j.ijcrp.2024.200338_bib6","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1161\/CIRCULATIONAHA.106.679597","article-title":"Diabetic cardiomyopathy revisited","volume":"115","author":"Boudina","year":"2007","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ijcrp.2024.200338_bib7","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1152\/physrev.00006.2004","article-title":"Myocardial substrate metabolism in the normal and failing heart","volume":"85","author":"Stanley","year":"2005","journal-title":"Physiol. Rev."},{"issue":"4","key":"10.1016\/j.ijcrp.2024.200338_bib8","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1007\/s00125-014-3171-6","article-title":"Molecular mechanisms of diabetic cardiomyopathy","volume":"57","author":"Bugger","year":"2014","journal-title":"Diabetologia"},{"issue":"5","key":"10.1016\/j.ijcrp.2024.200338_bib9","doi-asserted-by":"crossref","first-page":"E896","DOI":"10.1152\/ajpendo.00047.2004","article-title":"Cardiac mitochondrial damage and biogenesis in a chronic model of type 1 diabetes","volume":"287","author":"Shen","year":"2004","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"7","key":"10.1016\/j.ijcrp.2024.200338_bib10","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1042\/CS20130344","article-title":"Role of angiotensin-converting enzyme 2 (ACE2) in diabetic cardiovascular complications","volume":"126","author":"Patel","year":"2014","journal-title":"Clin Sci (Lond)."},{"issue":"7","key":"10.1016\/j.ijcrp.2024.200338_bib11","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1161\/CIRCULATIONAHA.111.076075","article-title":"Low myocardial protein kinase G activity in heart failure with preserved ejection fraction","volume":"126","author":"van Heerebeek","year":"2012","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.ijcrp.2024.200338_bib12","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/0002-9149(72)90595-4","article-title":"New type of cardiomyopathy associated with diabetic glomerulosclerosis","volume":"30","author":"Rubler","year":"1972","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcrp.2024.200338_bib13","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1161\/01.CIR.0000045671.62860.98","article-title":"Impact of glucose intolerance and insulin resistance on cardiac structure and function: sex-related differences in the Framingham Heart Study","volume":"107","author":"Rutter","year":"2003","journal-title":"Circulation"},{"issue":"21","key":"10.1016\/j.ijcrp.2024.200338_bib14","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1161\/CIRCULATIONAHA.119.042375","article-title":"Effect of empagliflozin on left ventricular mass in patients with type 2 diabetes mellitus and coronary artery disease:the EMPA-HEART CardioLink-6 randomized clinical trial","volume":"140","author":"Verma","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.ijcrp.2024.200338_bib15","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.echo.2011.07.017","article-title":"Diastolic dysfunction in patients with type 2 diabetes mellitus: is it really the first marker of diabetic cardiomyopathy?","volume":"24","author":"Ernande","year":"2011","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"10.1016\/j.ijcrp.2024.200338_bib16","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1530\/ERP-17-0052","article-title":"Evolution of subclinical myocardial dysfunction detected by two-dimensional and three-dimensional speckle tracking in asymptomatic type 1 diabetic patients: a long-term follow-up study","volume":"4","author":"Ringle","year":"2017","journal-title":"Echo Res Pract"},{"issue":"5","key":"10.1016\/j.ijcrp.2024.200338_bib17","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.3390\/ijms20051197","article-title":"Molecular mechanisms responsible for diastolic dysfunction in diabetes mellitus patients","volume":"20","author":"Nikolajevi\u0107 Star\u010devi\u0107","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijcrp.2024.200338_bib31","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.echo.2011.07.017","article-title":"Diastolic dysfunction in patients with type 2 diabetes mellitus: is it really the first marker of diabetic cardiomyopathy?","volume":"24","author":"Ernande","year":"2011","journal-title":"J. Am. Soc. Echocardiogr."},{"issue":"6","key":"10.1016\/j.ijcrp.2024.200338_bib18","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/1753-0407.12239","article-title":"Identification of a definite diabetic cardiomyopathy in type 2 diabetes by comprehensive echocardiographic evaluation: a cross-sectional comparison with non-diabetic weight-matched controls","volume":"7","author":"Ofstad","year":"2015","journal-title":"J. Diabetes"},{"key":"10.1016\/j.ijcrp.2024.200338_bib19","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1016\/j.jacc.2006.07.033","article-title":"Diastolic dysfunction and diabetic cardiomyopathy","author":"Galderisi","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcrp.2024.200338_bib20","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1136\/hrt.64.4.266","article-title":"Abnormal diastolic function in patients with type 1 diabetes and early nephropathy","volume":"64","author":"Sampson","year":"1990","journal-title":"Br. Heart J."},{"key":"10.1016\/j.ijcrp.2024.200338_bib21","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jacc.2009.12.003","article-title":"The development of heart failure in patients with diabetes mellitus and preclinical diastolic dysfunction a population-based study","volume":"55","author":"From","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcrp.2024.200338_bib22","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ijcard.2006.02.003","article-title":"Early diastolic impairment of diabetic heart: the significance of right ventricle","volume":"114","author":"Karamitsos","year":"2007","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcrp.2024.200338_bib23","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.115.003643","article-title":"Impact of improved glycemic control on cardiac function in type 2 diabetes mellitus","volume":"9","author":"Leung","year":"2016","journal-title":"Circ Cardiovasc Imaging"},{"issue":"19","key":"10.1016\/j.ijcrp.2024.200338_bib24","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1001\/jama.1979.03290450033020","article-title":"Diabetes and cardiovascular disease. The Framingham study","volume":"241","author":"Kannel","year":"1979","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ijcrp.2024.200338_bib25","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12933-017-0645-0","article-title":"Comparison of speckle-tracking echocardiography with invasive hemodynamics for the detection of characteristic cardiac dysfunction in type-1 and type-2 diabetic rat models","volume":"17","author":"M\u00e1ty\u00e1s","year":"2018","journal-title":"Cardiovasc. Diabetol."},{"issue":"4","key":"10.1016\/j.ijcrp.2024.200338_bib26","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1093\/ehjci\/jev164","article-title":"Left and right ventricular systolic function impairment in type 1 diabetic young adults assessed by 2D speckle tracking echocardiography","volume":"17","author":"J\u0119drzejewska","year":"2016","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.ijcrp.2024.200338_bib27","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.echo.2011.11.018","article-title":"Longitudinal left ventricular function in normotensive prediabetics: a tissue Doppler and strain\/strain rate echocardiography study","volume":"25","author":"Ceyhan","year":"2012","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"10.1016\/j.ijcrp.2024.200338_bib28","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1007\/s00125-010-1718-8","article-title":"Association of glucose metabolism with diastolic function along the diabetic continuum","volume":"53","author":"Stahrenberg","year":"2010","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.ijcrp.2024.200338_bib29","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/echo.13822","article-title":"Left ventricular myocardial performance index in prediabetic patients without coronary artery disease","volume":"35","author":"Askin","year":"2018","journal-title":"Echocardiography"},{"key":"10.1016\/j.ijcrp.2024.200338_bib30","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1016\/j.jacc.2017.07.792","article-title":"Clinical implications of echocardiographic phenotypes of patients with diabetes mellitus","volume":"70","author":"Ernande","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcrp.2024.200338_bib32","doi-asserted-by":"crossref","first-page":"448","DOI":"10.3906\/sag-1212-12","article-title":"Diastolic function of the right ventricle is impaired in experimental type 2 diabetic rat models","volume":"44","author":"Miao","year":"2014","journal-title":"Turk. J. Med. Sci."},{"key":"10.1016\/j.ijcrp.2024.200338_bib33","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.2337\/diacare.27.11.2736","article-title":"Right ventricular dysfunction in asymptomatic diabetic patients","volume":"27","author":"Kosmala","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ijcrp.2024.200338_bib34","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.echo.2014.11.017","article-title":"Right heart mechanics in untreated normotensive patients with prediabetes and type 2 diabetes mellitus: a two- and three-dimensional echocardiographic study","volume":"28","author":"Tadic","year":"2015","journal-title":"J. Am. Soc. Echocardiogr."},{"issue":"4","key":"10.1016\/j.ijcrp.2024.200338_bib35","first-page":"177","article-title":"Obvious or subclinical right ventricular dysfunction in diabetes mellitus (Type II): an echocardiographic tissue deformation study","volume":"7","author":"Parsaee","year":"2012","journal-title":"J Tehran Univ Heart Center"},{"issue":"16","key":"10.1016\/j.ijcrp.2024.200338_bib36","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1093\/eurjpc\/zwaa007","article-title":"Exercise capacity is related to attenuated responses in oxygen extraction and left ventricular longitudinal strain in asymptomatic type 2 diabetes patients","volume":"28","author":"Van Ryckeghem","year":"2022","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.ijcrp.2024.200338_bib37","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.echo.2017.12.006","article-title":"Dobutamine stress echocardiography unmasks early left ventricular dysfunction in asymptomatic patients with uncomplicated type 2 diabetes: a comprehensive two-dimensional speckle-tracking imaging study","volume":"31","author":"Philouze","year":"2018","journal-title":"J. Am. Soc. Echocardiog."},{"key":"10.1016\/j.ijcrp.2024.200338_bib38","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.echo.2016.10.003","article-title":"Dual-imaging stress echocardiography for prognostic assessment of high-risk asymptomatic patients with diabetes mellitus","volume":"30","author":"Cortigiani","year":"2017","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"10.1016\/j.ijcrp.2024.200338_bib39","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-004001","article-title":"Association of early adult modifiable cardiovascular risk factors with left atrial size over a 20-year follow-up period: the CARDIA study","volume":"4","author":"Armstrong","year":"2014","journal-title":"BMJ Open"},{"issue":"25","key":"10.1016\/j.ijcrp.2024.200338_bib40","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1016\/j.jacc.2013.08.1622","article-title":"Left atrial volume index: relation to long-term clinical outcome in type 2 diabetes","volume":"62","author":"Poulsen","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcrp.2024.200338_bib41","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10554-014-0536-3","article-title":"Left and right atrial phasic function and deformation in untreated patients with prediabetes and type 2 diabetes mellitus","volume":"31","author":"Tadic","year":"2015","journal-title":"Int. J. Cardiovasc. Imag."},{"key":"10.1016\/j.ijcrp.2024.200338_bib42","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s10840-012-9722-1","article-title":"Atrial conduction time and atrial mechanical function in patients with impaired fasting glucose","volume":"35","author":"Ayhan","year":"2012","journal-title":"J. Intervent. Card Electrophysiol."},{"issue":"2","key":"10.1016\/j.ijcrp.2024.200338_bib43","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s10554-018-1461-7","article-title":"Left atrial, ventricular and atrio-ventricular strain in patients with subclinical heart dysfunction","volume":"35","author":"Cameli","year":"2019","journal-title":"Int. J. Cardiovasc. Imag."},{"key":"10.1016\/j.ijcrp.2024.200338_bib44","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/j.amjcard.2004.07.143","article-title":"Three-dimensional assessment of left ventricular systolic strain in patients with type 2 diabetes mellitus, diastolic dysfunction, and normal ejection fraction","volume":"94","author":"Fonseca","year":"2004","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcrp.2024.200338_bib45","first-page":"72","article-title":"Evaluation of myocardial fibrosis in diabetes with cardiac magnetic resonance T1-mapping: correlation with the high-level hemoglobin A1c","volume":"150","author":"Gao","year":"2019","journal-title":"Diabetes Res"},{"issue":"1","key":"10.1016\/j.ijcrp.2024.200338_bib46","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12933-017-0651-2","article-title":"Increased myocardial extracellular volume assessed by cardiovascular magnetic resonance T1 mapping and its determinants in type 2 diabetes mellitus patients with normal myocardial systolic strain","author":"Cao","year":"2018","journal-title":"Cardiovasc. Diabetol."},{"issue":"2","key":"10.1016\/j.ijcrp.2024.200338_bib47","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1152\/japplphysiol.00012.2017","article-title":"Increased left ventricular extracellular volume and enhanced twist function in type 1 diabetic individuals","volume":"123","author":"Vasanji","year":"2017","journal-title":"J. Appl. Physiol."},{"issue":"1","key":"10.1016\/j.ijcrp.2024.200338_bib48","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/s12933-018-0782-0","article-title":"Left ventricular subclinical myocardial dysfunction in uncomplicated type 2 diabetes mellitus is associated with impaired myocardial perfusion: a contrast enhanced cardiovascular magnetic resonance study","volume":"17","author":"Liu","year":"2018","journal-title":"Cardiovasc. Diabetol."},{"issue":"1","key":"10.1016\/j.ijcrp.2024.200338_bib49","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-055374","article-title":"Association of myocardial fibrosis detected by late gadolinium-enhanced MRI with clinical outcomes in patients with diabetes: a systematic review and meta-analysis","volume":"12","author":"Yang","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.ijcrp.2024.200338_bib50","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/9584278","article-title":"Assessment of diabetic cardiomyopathy by cardiovascular magnetic resonance T1 mapping: correlation with left-ventricular diastolic dysfunction and diabetic duration","volume":"2017","author":"Shang","year":"2017","journal-title":"J. Diabetes Res."},{"issue":"1","key":"10.1016\/j.ijcrp.2024.200338_bib51","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1161\/CIRCIMAGING.111.965608","article-title":"Association between diffuse myocardial fibrosis by cardiac magnetic resonance contrast-enhanced T1 mapping and subclinical myocardial dysfunction in diabetic patients: a pilot study","volume":"5","author":"Ng","year":"2012","journal-title":"Circ Cardiovasc Imaging"},{"issue":"6","key":"10.1016\/j.ijcrp.2024.200338_bib52","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1161\/CIRCIMAGING.111.963587","article-title":"Association of imaging markers of myocardial fibrosis with metabolic and functional disturbances in early diabetic cardiomyopathy","volume":"4","author":"Jellis","year":"2011","journal-title":"Circ Cardiovasc Imaging"},{"issue":"5","key":"10.1016\/j.ijcrp.2024.200338_bib53","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.jcmg.2021.12.008","article-title":"Diabetes and myocardial fibrosis: a systematic review and meta- analysis","volume":"15","author":"Salvador","year":"2022","journal-title":"JACC Cardiovasc Imaging"},{"issue":"7","key":"10.1016\/j.ijcrp.2024.200338_bib54","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.120.011000","article-title":"Examining the relationship and prognostic implication of diabetic status and extracellular matrix expansion by cardiac magnetic resonance","volume":"13","author":"Khan","year":"2020","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.ijcrp.2024.200338_bib55","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12872-018-0770-z","article-title":"Epicardial adipose tissue is related to arterial sti ness and inflammation in patients with cardiovascular disease and type 2 diabetes","volume":"18","author":"Al-Talabany","year":"2018","journal-title":"BMC Cardiovasc. Disord."},{"key":"10.1016\/j.ijcrp.2024.200338_bib56","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1161\/CIRCULATIONAHA.106.645614","article-title":"Cardiac steatosis in diabetes mellitus: a 1H-magnetic resonance spectroscopy study","volume":"116","author":"McGavock","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.ijcrp.2024.200338_bib57","doi-asserted-by":"crossref","first-page":"44","DOI":"10.2337\/db15-0627","article-title":"Relationship between left ventricular structural and metabolic remodeling in type 2 diabetes","volume":"65","author":"Levelt","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.ijcrp.2024.200338_bib58","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.1093\/eurheartj\/ehv442","article-title":"Cardiac energetics, oxygenation, and perfusion during increased workload in patients with type 2 diabetes mellitus","volume":"37","author":"Levelt","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcrp.2024.200338_bib59","article-title":"Left atrial dysfunction in type 2 diabetes mellitus: insights from cardiac MRI [published online ahead of print July 17","author":"Graca","year":"2014","journal-title":"Eur. Radiol."},{"issue":"10","key":"10.1016\/j.ijcrp.2024.200338_bib60","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1093\/ehjci\/jew332","article-title":"Association of left atrial structure and function and incident cardiovascular disease in patients with diabetes mellitus: results from multi-ethnic study of atherosclerosis (MESA)","volume":"18","author":"Markman","year":"2017","journal-title":"European heart journal. Cardiovascular Imaging"},{"issue":"1","key":"10.1016\/j.ijcrp.2024.200338_bib61","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11154-010-9131-7","article-title":"Diabetic cardiomyopathy, causes and effects","volume":"11","author":"Boudina","year":"2010","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"10.1016\/j.ijcrp.2024.200338_bib62","first-page":"11","article-title":"Metformin ameliorates diabetic cardiomyopathy by activating the PK2\/PKR pathway","volume":"116","author":"Cheng","year":"2018","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"1 Pt A","key":"10.1016\/j.ijcrp.2024.200338_bib63","article-title":"Diabetic cardiomyopathy: 2023 update by the international multidisciplinary board of experts","volume":"49","author":"Avagimyan","year":"2024","journal-title":"Curr. Probl. Cardiol."},{"issue":"12","key":"10.1016\/j.ijcrp.2024.200338_bib64","first-page":"2004","article-title":"Adiponectin deficiency rescues diabetic cardiomyopathy by reversing the Lipotoxicity via mediating the lipid metabolic pathways","volume":"1832","author":"Guo","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ijcrp.2024.200338_bib65","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ijcha.2018.10.001","article-title":"Cardiologist and Diabetologist crosstalk in the era of cardiovascular outcome trials of novel glucose-lowering drugs","volume":"21","author":"Maranta","year":"2021","journal-title":"IJC Heart and Vasculature"},{"issue":"22","key":"10.1016\/j.ijcrp.2024.200338_bib66","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"EMPA-REG OUTCOME investigators. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"10254","key":"10.1016\/j.ijcrp.2024.200338_bib67","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S0140-6736(20)31824-9","article-title":"SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials","volume":"396","author":"Zannad","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ijcrp.2024.200338_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2023.131331","article-title":"Possibilities of dapagliflozin-induced cardioprotection on doxorubicin + cyclophosphamide mode of chemotherapy-induced cardiomyopathy","volume":"391","author":"Avagimyan","year":"2023","journal-title":"Int. J. Cardiol."},{"issue":"16","key":"10.1016\/j.ijcrp.2024.200338_bib69","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"EMPEROR-preserved trial investigators. Empagliflozin in heart failure with a preserved ejection fraction","volume":"385","author":"Anker","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.ijcrp.2024.200338_bib70","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1056\/NEJMoa2206286","article-title":"DELIVER trial committees and investigators. Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction","volume":"387","author":"Solomon","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.ijcrp.2024.200338_bib71","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/dom.12244","article-title":"Efficacy and safety of sodium glucose co-transport-2 inhibitors in type 2 diabetes: a meta-analysis of randomized clinical trials","volume":"16","author":"Monami","year":"2014","journal-title":"Diabetes Obes. Metabol."},{"issue":"2","key":"10.1016\/j.ijcrp.2024.200338_bib72","first-page":"180","article-title":"SGLT-2 inhibitors as promising therapeutic agents for heart failure with preserved ejection fraction: a review of current evidence and emerging concepts","volume":"23","author":"Razavi","year":"2021","journal-title":"Eur. J. Heart Fail."},{"issue":"12","key":"10.1016\/j.ijcrp.2024.200338_bib73","doi-asserted-by":"crossref","first-page":"e212","DOI":"10.2337\/dc16-1312","article-title":"Effect of empagliflozin on left ventricular mass and diastolic function in individuals with diabetes: an important clue to the EMPA-REG OUTCOME trial?","volume":"39","author":"Verma","year":"2016","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.ijcrp.2024.200338_bib74","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcrp.2024.200338_bib75","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.3389\/fphys.2018.01514","article-title":"Diabetic cardiomyopathy: current and future therapies. Beyond glycemic control","volume":"9","author":"Borghetti","year":"2018","journal-title":"Front. Physiol."},{"key":"10.1016\/j.ijcrp.2024.200338_bib76","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1124613","article-title":"Diabetic cardiomyopathy: the role of microRNAs and long non-coding RNAs","volume":"14","author":"Macvanin","year":"2023","journal-title":"Front. Endocrinol."},{"issue":"1","key":"10.1016\/j.ijcrp.2024.200338_bib77","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s12968-017-0397-8","article-title":"Adenosine stress CMR T1-mapping detects early microvascular dysfunction in patients with type 2 diabetes mellitus without obstructive coronary artery disease","volume":"19","author":"Levelt","year":"2017","journal-title":"J. Cardiovasc. Magn. Reson."},{"key":"10.1016\/j.ijcrp.2024.200338_bib78","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.echo.2014.02.010","article-title":"Prognostic meaning of coronary microvascular disease in type 2 diabetes mellitus: a transthoracic Doppler echocardiographic study","volume":"27","author":"Cortigiani","year":"2014","journal-title":"J. Am.Soc. Echocardiog."},{"key":"10.1016\/j.ijcrp.2024.200338_bib79","first-page":"80","article-title":"Cardiologist and Diabetologist crosstalk in the era of cardiovascular outcome trials of novel glucose-lowering drugs","volume":"21","author":"Maranta","year":"2018","journal-title":"Int. J. Cardiol. Heart Vasc."},{"issue":"19","key":"10.1016\/j.ijcrp.2024.200338_bib80","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1177\/2047487319858796","article-title":"Diastolic stress test in heart failure with preserved ejection fraction","volume":"27","author":"Sozzi","year":"2020","journal-title":"Eur. J. Prev. Cardiol."}],"container-title":["International Journal of Cardiology Cardiovascular Risk and Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S277248752400103X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S277248752400103X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T18:51:25Z","timestamp":1732733485000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S277248752400103X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":80,"alternative-id":["S277248752400103X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcrp.2024.200338","relation":{},"ISSN":["2772-4875"],"issn-type":[{"value":"2772-4875","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diabetic cardiomyopathy: pathophysiology, imaging assessment and therapeutical strategies","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology Cardiovascular Risk and Prevention","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcrp.2024.200338","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"200338"}}